FIELD: chemistry.
SUBSTANCE: invention relates to new steroid compounds of formula (I): or its physiologically acceptable solvate.
EFFECT: compound has glucocorticoid agonistic activity and can be used in treating inflammatory and allergenic diseases.
27 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
SPECIFIC GLYCOCOTRICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT | 2004 |
|
RU2348645C2 |
16α,17a-ACETAL-SUBSTITUTED ANDROSTANE-17b-CARBOXYLIC ACID ESTERS OR THEIR STEREOISOMERS | 1991 |
|
RU2081879C1 |
DERIVATIVE OF PHENETHANOLAMINE FOR TREATMENT OF RESPIRATORY DISEASE | 2002 |
|
RU2312854C2 |
METHOD FOR OBTAINING FLUTICASONE PROPIONATE OBTAINING, PARTICULARLY POLYMORPHOUS FORM 1 | 2003 |
|
RU2333218C2 |
ARYLALANINE DERIVATIVES AS AGONISTS OF β ADRENERGIC RECEPTOR | 2005 |
|
RU2370490C2 |
APPLICATION OF H, K-ATPase INHIBITOR FOR TREATING NASAL POLYPS | 1997 |
|
RU2197966C2 |
AMINO-SUBSTITUTED ETHYLAMINO-AGONISTS OF β-ADRENERGIC RECEPTORS | 2004 |
|
RU2385317C2 |
DERIVATIVES OF ANDROSTENE, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2194053C2 |
METHOD FOR OBTAINING 6α, 9α-DIFLUOR- 17α-(1-OXO-PROPOXY)-11β-HYDROXY-16α-METHYL-3-OXO-ANDROST-1,4-DIENE-17β-CARBOTHIONE ACID | 2003 |
|
RU2333217C2 |
COMBINATION OF COMPOUNDS, WHICH CAN BE APPLIED IN TREATMENT OF RESPIRATORY DISEASES, ESPECIALLY CHRONICAL OBSTRUCTIVE LUNG DISEASE (COLD) AND ASTHMA | 2006 |
|
RU2414222C2 |
Authors
Dates
2009-06-27—Published
2004-07-09—Filed